Brief: Tango Therapeutics Presents Preclinical Data On Precision Oncology Programs
18/04/2023 21:31
April 18 (Reuters) - Tango Therapeutics Inc TNGX.O :
* TANGO THERAPEUTICS PRESENTS PRECLINICAL DATA ON PRECISION
ONCOLOGY PROGRAMS AT THE AMERICAN ASSOCIATION OF CANCER RESEARCH
2023 ANNUAL MEETING
Source text for Eikon: ID:nGNXzplPn
Further company coverage: TNGX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tango Therapeutics
See all newsBrief: Tango Therapeutics, Inc. Approved A Strategic Reprioritization Of The Company’S Research And Development Activities
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tango Therapeutics - Files Prospectus To Sell Up To $400 Million In Common Stock
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,